A carregar...
COVID‐19 patients benefit from early antiviral treatment: A comparative, retrospective study
The outbreak of COVID‐19, caused by severe acute respiratory syndrome coronavirus 2, started in December 2019, Wuhan, China. We aimed to figure out the time‐point and duration of using antiviral drugs for receiving the maximal effects in patients with COVID‐19. In this study, we enrolled 129 confirm...
Na minha lista:
| Publicado no: | J Med Virol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300891/ https://ncbi.nlm.nih.gov/pubmed/32492205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26129 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|